Physician profile
Gerald B Millick
NPI 1477874584
$2,353.03
in general payments reported to CMS, 2019-2025
9 companies · $73.53 in 2025
The $73.53 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $99.51 · 2021: $250 · 2022: $13.18 · 2023: $23.85 · 2024: $1,693 · 2025: $73.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,272 · Food and Beverage: $343 · Gift: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,272.38 |
| Food and Beverage | $342.67 |
| Gift | $175.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,793.66 | 2020-2024 | |
| Endogastric Solutions, INC | $195.77 | 2019-2021 | |
| Ethicon US, LLC | $138.13 | 2021-2025 | Stratafix, Linx Reflux Management System, Echelon Flex |
| Medical Device Business Services, INC. | $109.50 | 2021 | |
| Medtronic, INC. | $42.79 | 2023-2024 | Manoscan, Ligasure |
| Vertex Pharmaceuticals Incorporated | $30.34 | 2025 | |
| Cook Medical LLC | $16.10 | 2025 | Hemospray |
| Zimmer Biomet Holdings, INC. | $13.56 | 2019 | |
| Novo Nordisk INC | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Millick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.